Thomas D. Bannister

3.7k total citations · 1 hit paper
78 papers, 2.4k citations indexed

About

Thomas D. Bannister is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Thomas D. Bannister has authored 78 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 28 papers in Organic Chemistry and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Thomas D. Bannister's work include Receptor Mechanisms and Signaling (14 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and Neuropeptides and Animal Physiology (8 papers). Thomas D. Bannister is often cited by papers focused on Receptor Mechanisms and Signaling (14 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and Neuropeptides and Animal Physiology (8 papers). Thomas D. Bannister collaborates with scholars based in United States, Germany and Australia. Thomas D. Bannister's co-authors include Michael D. Cameron, William Roush, Nicole Kennedy, Cullen L. Schmid, Laura Bohn, Zhizhou Yue, Nicolette C. Ross, Kimberly M. Lovell, Michael Wendt and Jenny Morgenweck and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Thomas D. Bannister

77 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics

2017 372 citations Cullen L. Schmid, Nicole Kennedy et al. profile →

Peers

Thomas D. Bannister

CMN

PHARM

PHYSI

Na Ye China

Werner J. Geldenhuys United States

Giovanni Greco Italy

Sung Bae Lee South Korea

Carlos Davio Argentina

Samarjit Patnaik United States

Magid Abou‐Gharbia United States

Simona Daniele Italy

Philippe Delcourt France

Keld Fosgerau Denmark

Na Ye China

Thomas D. Bannister

1.2k ×1.0

692 ×1.0

249 ×0.5

CMN

171 ×1.0

PHARM

118 ×0.7

PHYSI

Citations per year, relative to Thomas D. Bannister Thomas D. Bannister (= 1×) peers Na Ye

Countries citing papers authored by Thomas D. Bannister

Since Specialization

Citations

This map shows the geographic impact of Thomas D. Bannister's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas D. Bannister with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas D. Bannister more than expected).

Fields of papers citing papers by Thomas D. Bannister

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas D. Bannister. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas D. Bannister. The network helps show where Thomas D. Bannister may publish in the future.

Co-authorship network of co-authors of Thomas D. Bannister

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas D. Bannister. A scholar is included among the top collaborators of Thomas D. Bannister based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas D. Bannister. Thomas D. Bannister is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pol, Christine J., Ioannis D. Kyriazis, Matthew Hoffman, et al.. (2025). Cardiac ischaemia/reperfusion in pigs and mice increases cardiomyocyte Krüppel-like factor 5 that aggravates tissue injury and remodelling. Cardiovascular Research. 121(6). 900–914. 1 indexed citations

Selsted, Michael E., et al.. (2024). An ADAM10 Exosite Inhibitor Is Efficacious in an In Vivo Collagen-Induced Arthritis Model. Pharmaceuticals. 17(1). 87–87. 1 indexed citations

Otsuka, Yuka, Eunjung Kim, Chao Wang, et al.. (2024). High throughput screening for SARS-CoV-2 helicase inhibitors. SLAS DISCOVERY. 29(6). 100180–100180. 3 indexed citations

Moghadasi, Seyed Arad, Yuka Otsuka, Christina B. Cooley, et al.. (2024). SARS-CoV-2 Mpro inhibitor identification using a cellular gain-of-signal assay for high-throughput screening. SLAS DISCOVERY. 29(6). 100181–100181. 2 indexed citations

Smith, Emery, Meredith E. Davis-Gardner, Rubén D. Garcia-Ordoñez, et al.. (2023). High throughput screening for drugs that inhibit 3C-like protease in SARS-CoV-2. SLAS DISCOVERY. 28(3). 95–101. 13 indexed citations

Coant, Nicolas, John D. Bickel, Ronald J. Rahaim, et al.. (2023). Neutral ceramidase-active site inhibitor chemotypes and binding modes. Bioorganic Chemistry. 139. 106747–106747. 1 indexed citations

Primi, Marina Candido, Claudia Ruiz, Thales Kronenberger, et al.. (2023). HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents. European Journal of Medicinal Chemistry. 263. 115935–115935. 4 indexed citations

Hoffman, Matthew, Ioannis D. Kyriazis, Maria Cimini, et al.. (2021). Cardiomyocyte Krüppel-Like Factor 5 Promotes De Novo Ceramide Biosynthesis and Contributes to Eccentric Remodeling in Ischemic Cardiomyopathy. Circulation. 143(11). 1139–1156. 39 indexed citations

Kyriazis, Ioannis D., Matthew Hoffman, Anna Maria Lucchese, et al.. (2020). KLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy. Circulation Research. 128(3). 335–357. 107 indexed citations

10.

Mediouni, Sonia, Joseph Jablonski, Cari F. Kessing, et al.. (2020). Oregano Oil and Its Principal Component, Carvacrol, Inhibit HIV-1 Fusion into Target Cells. Journal of Virology. 94(15). 45 indexed citations

11.

Grim, Travis W., Cullen L. Schmid, Nicole Kennedy, et al.. (2020). Comparison of morphine, oxycodone and the biased MOR agonist SR-17018 for tolerance and efficacy in mouse models of pain. Neuropharmacology. 185. 108439–108439. 20 indexed citations

12.

Prabhu, Antony, Kristen E.N. Scott, Paul A. Stewart, et al.. (2020). A22 Integrated Proteometabolomic Analysis Reveals Metabolic Vulnerabilities in Small-Cell Lung Cancer. Journal of Thoracic Oncology. 15(2). S19–S19. 1 indexed citations

13.

Smith, Emery, Jo Ann Janovick, Thomas D. Bannister, et al.. (2020). Rescue of mutant gonadotropin-releasing hormone receptor function independent of cognate receptor activity. Scientific Reports. 10(1). 10579–10579. 7 indexed citations

14.

Wang, Chao, et al.. (2019). The Novel Small-Molecule SR18662 Efficiently Inhibits the Growth of Colorectal Cancer In Vitro and In Vivo. Molecular Cancer Therapeutics. 18(11). 1973–1984. 10 indexed citations

15.

Nieto, Ainhoa, Virneliz Fernández-Vega, Timothy Spicer, et al.. (2018). Identification of Novel, Structurally Diverse, Small Molecule Modulators of GPR119. Assay and Drug Development Technologies. 16(5). 278–288. 5 indexed citations

16.

Wang, Chao, Yuanjun He, Mónica Garcı́a-Barros, et al.. (2015). ML264, A Novel Small-Molecule Compound That Potently Inhibits Growth of Colorectal Cancer. Molecular Cancer Therapeutics. 15(1). 72–83. 53 indexed citations

17.

Buckner, Frederick S., Ranae M. Ranade, Franck Madoux, et al.. (2014). Identification of Potent Inhibitors of the Trypanosoma brucei Methionyl-tRNA Synthetase via High-Throughput Orthogonal Screening. SLAS DISCOVERY. 20(1). 122–130. 32 indexed citations

18.

Andero, Raül, Shaun P. Brothers, Tanja Jovanović, et al.. (2013). Amygdala-Dependent Fear Is Regulated by Oprl1 in Mice and Humans with PTSD. Science Translational Medicine. 5(188). 188ra73–188ra73. 118 indexed citations

19.

Bialkowska, Agnieszka B., Melissa Crisp, Thomas D. Bannister, et al.. (2011). Identification of Small-Molecule Inhibitors of the Colorectal Cancer Oncogene Krüppel-like Factor 5 Expression by Ultrahigh-Throughput Screening. Molecular Cancer Therapeutics. 10(11). 2043–2051. 37 indexed citations

20.

Shirodaria, Cheerag, Colin Cunnington, Ilias Kylintireas, et al.. (2008). High Dose Modified-release Nicotinic Acid Reduces Carotid Atherosclerosis: a Randomized, Placebo-controlled Magnetic Resonance Study. Circulation. 118. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact